Newer parameters of the octreotide test in patients with acromegaly.

Shin UraiMasaaki YamamotoNaoki YamamotoMasaki SuzukiHiroki ShichiKeitaro KanieYasunori FujitaHironori BandoHidenori FukuokaMichiko TakahashiGenzo IguchiYutaka TakahashiWataru Ogawa

Published in: Pituitary (2023)

The AUC and time to nadir GH level may potentially be newer parameters of the octreotide test for estimating the therapeutic effect of fg-SRLs.

Keyphrases

neuroendocrine tumors
growth hormone